
DNA Synthesizer Market Report and Forecast 2025-2034
Description
The global DNA synthesizer market size was valued at USD 261.06 Million in 2024, driven by the increasing demand for efficient DNA synthesizers across the globe. The market size is anticipated to grow at a CAGR of 14.40% during the forecast period of 2025-2034 to achieve a value of USD 1002.31 Million by 2034.
DNA Synthesizer: Introduction
DNA synthesizers are devices that produce DNA molecules with a specific sequence of nucleotides. These molecules can be utilized to treat diseases by replacing damaged DNA with repaired sections. A DNA synthesizer is a crucial laboratory instrument used to chemically create or synthesize DNA molecules. It plays a vital role in molecular biology, genetics, and biotechnology research, as it enables scientists to design custom DNA sequences for different purposes, including cloning, gene expression studies, genetic engineering, and DNA sequencing.
Global DNA Synthesizer Market Analysis
The increasing demand for DNA synthesis technology is due to the widespread application in research to better understand the mechanisms of disease and in the drug discovery process to combat disease is a major trend influencing the market growth.
The continuous research and development activities by biotech firms and other institutions are also majorly contributing to the global DNA synthesizer market growth. For example, recently this year, Ansa Biotechnologies, Inc. claimed a successful creation of the world’s longest DNA oligonucleotide in a single synthesis. The 1005-base sequence codes for a key part of an adeno-associated virus vector used to develop gene therapy.
The market is experiencing heavy investments by synthetic biology companies that are interested in developing new technological advancements in this area, further expected to expand the market growth. For example, a UK-based synthetic biology company, Camena Bioscience, recently announced the closing of a USD 10 million Series A financing round, led by Mercia, a UK-based venture capital firm. Camena aims to scale operations and continue developing gSynth, its enzyme-based DNA synthesis platform.
Global DNA Synthesizer Market Segmentations
DNA Synthesizer Market Report and Forecast 2025-2034 offers a detailed analysis of the market based on the following segments:
Market Breakup by Type
The growth of the market is expected to be driven by the increasing demand for efficient DNA synthesizers from life science laboratories and pharmaceutical and biotechnology companies. Another key factor is the rapid developments in genomics and life sciences, boosting the market growth further. The increasing significance of DNA synthesizers in synthetic and molecular biology is also supporting the market growth. The market is also experiencing high demand for nucleic acid synthesis platforms among several end users, further propelling the global DNA synthesizer market growth.
The increasing technological advancements are also a key factor driving the global market. The proven efficacy of benchtop DNA synthesizers as they increase the speed and efficiency of research in academic and industrial labs is contributing to the increased demand in the market, further expected to boost the growth of the market in the coming years.
The efforts to lower the cost of synthesizing DNA oligonucleotides and commercialize scalable DNA synthesizers are continuously increasing. Significant progress has been made towards the goal of affordable DNA synthesis with microfluidic/microarray oligonucleotide synthesis methods and improvements in synthetic DNA quality.
Furthermore, ongoing advancements in other efficient synthesis technologies are also expected to make synthesizers widely available at lower costs, adding further value to the global DNA synthesizer market share.
North America is currently leading the global market and is expected to keep leading throughout the forecast period due to the presence of several key players in the market and their continuous developments. Moreover, the market is also driven by ongoing technological advancements, increased investment in research and development activities, and growing demand for innovative synthesizers.
Global DNA Synthesizer Market: Competitor Landscape
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
DNA Synthesizer: Introduction
DNA synthesizers are devices that produce DNA molecules with a specific sequence of nucleotides. These molecules can be utilized to treat diseases by replacing damaged DNA with repaired sections. A DNA synthesizer is a crucial laboratory instrument used to chemically create or synthesize DNA molecules. It plays a vital role in molecular biology, genetics, and biotechnology research, as it enables scientists to design custom DNA sequences for different purposes, including cloning, gene expression studies, genetic engineering, and DNA sequencing.
Global DNA Synthesizer Market Analysis
The increasing demand for DNA synthesis technology is due to the widespread application in research to better understand the mechanisms of disease and in the drug discovery process to combat disease is a major trend influencing the market growth.
The continuous research and development activities by biotech firms and other institutions are also majorly contributing to the global DNA synthesizer market growth. For example, recently this year, Ansa Biotechnologies, Inc. claimed a successful creation of the world’s longest DNA oligonucleotide in a single synthesis. The 1005-base sequence codes for a key part of an adeno-associated virus vector used to develop gene therapy.
The market is experiencing heavy investments by synthetic biology companies that are interested in developing new technological advancements in this area, further expected to expand the market growth. For example, a UK-based synthetic biology company, Camena Bioscience, recently announced the closing of a USD 10 million Series A financing round, led by Mercia, a UK-based venture capital firm. Camena aims to scale operations and continue developing gSynth, its enzyme-based DNA synthesis platform.
Global DNA Synthesizer Market Segmentations
DNA Synthesizer Market Report and Forecast 2025-2034 offers a detailed analysis of the market based on the following segments:
Market Breakup by Type
- Benchtop DNA Synthesizers
- Large-scale DNA Synthesizers
- Research and Development
- Academic
- Industrial
- Diagnosis
- Therapeutics
- Biopharmaceutical Companies
- Academic and Research Institutes
- Contract Research Organizations
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
The growth of the market is expected to be driven by the increasing demand for efficient DNA synthesizers from life science laboratories and pharmaceutical and biotechnology companies. Another key factor is the rapid developments in genomics and life sciences, boosting the market growth further. The increasing significance of DNA synthesizers in synthetic and molecular biology is also supporting the market growth. The market is also experiencing high demand for nucleic acid synthesis platforms among several end users, further propelling the global DNA synthesizer market growth.
The increasing technological advancements are also a key factor driving the global market. The proven efficacy of benchtop DNA synthesizers as they increase the speed and efficiency of research in academic and industrial labs is contributing to the increased demand in the market, further expected to boost the growth of the market in the coming years.
The efforts to lower the cost of synthesizing DNA oligonucleotides and commercialize scalable DNA synthesizers are continuously increasing. Significant progress has been made towards the goal of affordable DNA synthesis with microfluidic/microarray oligonucleotide synthesis methods and improvements in synthetic DNA quality.
Furthermore, ongoing advancements in other efficient synthesis technologies are also expected to make synthesizers widely available at lower costs, adding further value to the global DNA synthesizer market share.
North America is currently leading the global market and is expected to keep leading throughout the forecast period due to the presence of several key players in the market and their continuous developments. Moreover, the market is also driven by ongoing technological advancements, increased investment in research and development activities, and growing demand for innovative synthesizers.
Global DNA Synthesizer Market: Competitor Landscape
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
- LGC Biosearch Technologies
- Bioneer Corporation
- Thermo Fisher Scientific, Inc.
- IBA GmbH
- Twist Bioscience
- Eton Bioscience
- Quintara Biosciences
- Eurofins Scientific
- Integrated DNA Technologies, Inc
- Integrated DxNA Technologies, Inc
Table of Contents
350 Pages
- 1 Preface
- 1.1 Objectives of the Study
- 1.2 Key Assumptions
- 1.3 Report Coverage – Key Segmentation and Scope
- 1.4 Research Methodology
- 2 Executive Summary
- 3 Global DNA Synthesizer Market Overview
- 3.1 Global DNA Synthesizer Market Historical Value (2018-2024)
- 3.2 Global DNA Synthesizer Market Forecast Value (2025-2034)
- 4 Global DNA Synthesizer Market Landscape
- 4.1 DNA Synthesizer: Developers Landscape
- 4.1.1 Analysis by Year of Establishment
- 4.1.2 Analysis by Company Size
- 4.1.3 Analysis by Region
- 4.2 DNA Synthesizer: Product Landscape
- 4.2.1 Analysis by Application
- 4.2.2 Analysis by Type
- 4.2.3 Analysis by End User
- 5 Global DNA Synthesizer Market Dynamics
- 5.1 Market Drivers and Constraints
- 5.2 SWOT Analysis
- 5.3 Porter’s Five Forces Model
- 5.4 Key Demand Indicators
- 5.5 Key Price Indicators
- 5.6 Industry Events, Initiatives, and Trends
- 5.7 Value Chain Analysis
- 6 Global DNA Synthesizer Market Segmentation
- 6.1 Global DNA Synthesizer Market by Type
- 6.1.1 Market Overview
- 6.1.2 Benchtop DNA Synthesizers
- 6.1.3 Large-scale DNA Synthesizers
- 6.2 Global DNA Synthesizer Market by Application
- 6.2.1 Market Overview
- 6.2.2 Research and Development
- 6.2.3 Academic
- 6.2.4 Industrial
- 6.2.5 Diagnosis
- 6.2.6 Therapeutics
- 6.3 Global DNA Synthesizer Market by End User
- 6.3.1 Market Overview
- 6.3.2 Biopharmaceutical Companies
- 6.3.3 Academic and Research Institutes
- 6.3.4 Contract Research Organizations
- 6.4 Global DNA Synthesizer Market by Region
- 6.4.1 Market Overview
- 6.4.2 North America
- 6.4.3 Europe
- 6.4.4 Asia Pacific
- 6.4.5 Latin America
- 6.4.6 Middle East and Africa
- 7 North America DNA Synthesizer Market
- 7.1 Market Share by Country
- 7.2 United States of America
- 7.3 Canada
- 8 Europe DNA Synthesizer Market
- 8.1 Market Share by Country
- 8.2 United Kingdom
- 8.3 Germany
- 8.4 France
- 8.5 Italy
- 8.6 Others
- 9 Asia Pacific DNA Synthesizer Market
- 9.1 Market Share by Country
- 9.2 China
- 9.3 Japan
- 9.4 India
- 9.5 ASEAN
- 9.6 Australia
- 9.7 Others
- 10 Latin America DNA Synthesizer Market
- 10.1 Market Share by Country
- 10.2 Brazil
- 10.3 Argentina
- 10.4 Mexico
- 10.5 Others
- 11 Middle East and Africa DNA Synthesizer Market
- 11.1 Market Share by Country
- 11.2 Saudi Arabia
- 11.3 United Arab Emirates
- 11.4 Nigeria
- 11.5 South Africa
- 11.6 Others
- 12 Regulatory Framework
- 12.1 Regulatory Overview
- 12.1.1 US FDA
- 12.1.2 EU EMA
- 12.1.3 INDIA CDSCO
- 12.1.4 JAPAN PMDA
- 12.1.5 Others
- 13 Patent Analysis
- 13.1 Analysis by Type of Patent
- 13.2 Analysis by Publication year
- 13.3 Analysis by Issuing Authority
- 13.4 Analysis by Patent Age
- 13.5 Analysis by CPC Analysis
- 13.6 Analysis by Patent Valuation
- 13.7 Analysis by Key Players
- 14 Grants Analysis
- 14.1 Analysis by year
- 14.2 Analysis by Amount Awarded
- 14.3 Analysis by Issuing Authority
- 14.4 Analysis by Grant Application
- 14.5 Analysis by Funding Institute
- 14.6 Analysis by NIH Departments
- 14.7 Analysis by Recipient Organization
- 15 Funding and Investment Analysis
- 15.1 Analysis by Funding Instances
- 15.2 Analysis by Type of Funding
- 15.3 Analysis by Funding Amount
- 15.4 Analysis by Leading Players
- 15.5 Analysis by Leading Investors
- 15.6 Analysis by Geography
- 16 Partnership and Collaborations Analysis
- 16.1 Analysis by Partnership Instances
- 16.2 Analysis by Type of Partnership
- 16.3 Analysis by Leading Players
- 16.4 Analysis by Geography
- 17 Supplier Landscape
- 17.1 LGC Biosearch Technologies
- 17.1.1 Financial Analysis
- 17.1.2 Product Portfolio
- 17.1.3 Demographic Reach and Achievements
- 17.1.4 Mergers and Acquisitions
- 17.1.5 Certifications
- 17.2 Bioneer Corporation
- 17.2.1 Financial Analysis
- 17.2.2 Product Portfolio
- 17.2.3 Demographic Reach and Achievements
- 17.2.4 Mergers and Acquisitions
- 17.2.5 Certifications
- 17.3 Thermo Fisher Scientific, Inc.
- 17.3.1 Financial Analysis
- 17.3.2 Product Portfolio
- 17.3.3 Demographic Reach and Achievements
- 17.3.4 Mergers and Acquisitions
- 17.3.5 Certifications
- 17.4 IBA GmbH
- 17.4.1 Financial Analysis
- 17.4.2 Product Portfolio
- 17.4.3 Demographic Reach and Achievements
- 17.4.4 Mergers and Acquisitions
- 17.4.5 Certifications
- 17.5 Twist Bioscience
- 17.5.1 Financial Analysis
- 17.5.2 Product Portfolio
- 17.5.3 Demographic Reach and Achievements
- 17.5.4 Mergers and Acquisitions
- 17.5.5 Certifications
- 17.6 Eton Bioscience
- 17.6.1 Financial Analysis
- 17.6.2 Product Portfolio
- 17.6.3 Demographic Reach and Achievements
- 17.6.4 Mergers and Acquisitions
- 17.6.5 Certifications
- 17.7 Quintara Biosciences
- 17.7.1 Financial Analysis
- 17.7.2 Product Portfolio
- 17.7.3 Demographic Reach and Achievements
- 17.7.4 Mergers and Acquisitions
- 17.7.5 Certifications
- 17.8 Eurofins Scientific
- 17.8.1 Financial Analysis
- 17.8.2 Product Portfolio
- 17.8.3 Demographic Reach and Achievements
- 17.8.4 Mergers and Acquisitions
- 17.8.5 Certifications
- 17.9 Integrated DNA Technologies, Inc
- 17.9.1 Financial Analysis
- 17.9.2 Product Portfolio
- 17.9.3 Demographic Reach and Achievements
- 17.9.4 Mergers and Acquisitions
- 17.9.5 Certifications
- 17.10 Integrated DxNA Technologies, Inc
- 17.10.1 Financial Analysis
- 17.10.2 Product Portfolio
- 17.10.3 Demographic Reach and Achievements
- 17.10.4 Mergers and Acquisitions
- 17.10.5 Certifications
- 18 Key Opinion Leaders (KOL) Insights (Additional Insight)
- 19 Company Competitiveness Analysis (Additional Insight)
- 19.1 Very Small Companies
- 19.2 Small Companies
- 19.3 Mid-Sized Companies
- 19.4 Large Companies
- 19.5 Very Large Companies
- 20 Payment Methods (Additional Insight)
- 20.1 Government Funded
- 20.2 Private Insurance
- 20.3 Out-of-Pocket
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.